New approach to crohn’s disease combines a whole food diet with modulen, proven to induce and maintain disease remission
Lausanne, Switzerland, July 25, 2019 -- A new randomized controlled trial has found that combining the Crohn’s Disease Exclusion Diet, the only whole-food based dietary approach to the disease, with Modulen is effective for the management of Crohn’s disease.
The trial demonstrated that 80% of patients on the combined therapy approach achieved remission from Crohn’s disease at week six, versus 73.5% of patients taking exclusively enteral nutrition; at week 12, the results were 70% and 42.5% respectively.
“This is a breakthrough,” said Professor Arie Levine, the leading Paediatric Gastroenterologist at Wolfson Medical Center in Israel, who designed the Crohn’s Disease Exclusion Diet (CDED) and researched it in partnership with Nestlé Health Science. He added, “The disruptive clinical data changes our view regarding the future treatment of Crohn’s disease. This highly effective treatment has no side effects and will be accessible to all healthcare professionals.”
